diff --git a/src/.DS_Store b/src/.DS_Store
index f64d567c5923a87c71d80b5d6e8611993da89e91..9bfb9d1a944c699cab90c14d7d7a7ed9b0d19385 100644
Binary files a/src/.DS_Store and b/src/.DS_Store differ
diff --git a/src/App/mediarules.css b/src/App/mediarules.css
index 79f85686471980c4b94d055843dc15e55e70f236..e9c35b46e3730655004f0ad3c7cb14af41174ee8 100644
--- a/src/App/mediarules.css
+++ b/src/App/mediarules.css
@@ -50,7 +50,7 @@
         max-width: 100% !important;
       }
       .col-6 {
-        width: 100%; /* Full width for smartphone */
+        width: 100% !important; /* Full width for smartphone */
       }
       .container-fluid {
         min-height: 100vh; /* Füllt den gesamten Bildschirm aus */
diff --git a/src/data/hptimelinedata.tsx b/src/data/hptimelinedata.tsx
index d73889a5b92a156f4057801945d4692dba73a36e..24411455a35411388227850433d4ceece76dbf5a 100644
--- a/src/data/hptimelinedata.tsx
+++ b/src/data/hptimelinedata.tsx
@@ -779,7 +779,6 @@ export const timelinedata: Array<TimelineDatenpunkt>  = [
     aimofcontact: "",
     insights: "",
     implementation: "",
-    type: "meta",
     summary: "",
     months: "june"
   },
@@ -1400,7 +1399,6 @@ export const timelinedata: Array<TimelineDatenpunkt>  = [
       This knowledge is crucial as we think about the future of our project, particularly if we aim to move our gene therapy approach for cystic fibrosis closer to clinical trials and real-world applications. My participation in the GXP training has equipped me with the necessary tools to potentially guide our team through the complex regulatory landscape, ensuring our work remains aligned with industry standards and ready for the next steps in development. 
       One of the key speakers during the GXP course was Dr. Marcus Berger [LINK INtreview Beerger], whose expertise was invaluable to me and the entire team. After the course, I had the opportunity to ask Dr. Berger some questions, further deepening my understanding of the practical applications of GXP in research. The connection with Dr. Berger has been highly beneficial, as his insights helped shape key aspects of our project’s development and compliance with industry standards. His guidance will continue to be a valuable resource for our team moving forward. 
       Through this training, I feel better positioned to contribute to the team’s efforts, ensuring our project adheres to global safety and ethical guidelines. This experience has strengthened our approach and set a solid foundation for future progress, ensuring that our research, public engagement, and potential clinical applications continue to meet the highest regulatory standards. </p>],
-    type: "meta",
     summary: "Kaya, a member of the iGEM Bielefeld 2024 team, completed an intensive one-week GXP (Good Practice) training, which covered Good Laboratory Practice (GLP), Good Clinical Practice (GCP), and Good Manufacturing Practice (GMP). The training provided valuable insights into maintaining high standards of quality, safety, and ethics throughout the research process. Kaya learned crucial skills, such as documenting research processes for reproducibility, creating standard operating procedures (SOPs), and conducting risk assessments using techniques like Failure Mode and Effects Analysis (FMEA). This knowledge is essential for advancing their cystic fibrosis gene therapy project toward clinical trials and ensuring compliance with regulatory standards. Dr. Marcus Berger, a key speaker in the course, provided additional guidance, offering valuable insights that will continue to benefit the team.",
     months: "august",
     pictureurl_implementation: "https://static.igem.wiki/teams/5247/photos/for-wiki-texts/gxp/gxp-course-kaya.webp",